Compass Therapeutics Inc. (CMPX) NASDAQ

$1.50 0.01 (0.67%)

Market Cap: $205.01M

As of 04/19/24 10:58 AM EDT. Market open.

(CMPX)

Compass Therapeutics Inc. (CMPX)
NASDAQ

$1.50
0.01 (0.67%)

Market Cap: $205.01M

As of 04/19/24 10:58 AM EDT. Market open.

Add to Portfolio

compass therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human monoclonal antibodies, multiclonals, and engineered protein constructs. compass is industrializing antibody discovery and decentralizing biologic validation through a partnership-first mentality that leverages best-in-class technologies and ... read more

compass therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human monoclonal antibodies, multiclonals, and engineered protein constructs. compass is industrializing antibody discovery and decentralizing biologic validation through a partnership-first mentality that leverages best-in-class technologies and top-tier academic laboratories around the world. novel scientific insights are validated and explored deeply inside our labs before compass pursues the best proprietary combinations of therapeutics into human clinical trials. in 2015, compass quietly closed a $120mm series a financing to fund our ambitious plan to build a fully-integrated biopharmaceutical company from the ground up. our investors are among the most sophisticated venture capitalists in the industry who exemplify our philosophy of building long term economic value only by delivering therapeutics with meaningful efficacy beyond read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
35
URL
Address
.
PRICE CHART FOR COMPASS THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.55
Previous Close
$1.49
Days Range
$1.48 - $1.71
52 week range
$1.15 - $3.62
Volume
80,387
Avg. Volume (30 days)
369,792
Market Cap
$205.01M
Dividend Yield
-
P/E
-
Shares Outstanding
137,589,171
Open
$1.55
Previous Close
$1.49
Days Range
$1.48 - $1.71
52 week range
$1.15 - $3.62
Volume
80,387
Avg. Volume (30 days)
369,792
Market Cap
$205.01M
Dividend Yield
-
P/E
-
Shares Outstanding
137,589,171
FINANCIAL STATEMENTS FOR COMPASS THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR COMPASS THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Bisker-Leib VeredCHIEF EXECUTIVE OFFICERFeb 08, 2024 Option Exercise$1.4549,19871,3373,124,426Feb 09, 2024, 12:50 PM
Schuetz Thomas J.PRESIDENTFeb 08, 2024 Option Exercise$1.4544,78264,9346,570,566Feb 09, 2024, 12:49 PM
Bisker-Leib VeredChief Executive OfficerJan 09, 2024 Option Exercise$1.931,753,1253,383,5313,173,624Jan 10, 2024, 10:31 AM
Schuetz Thomas J.President of R&DJan 09, 2024 Option Exercise$1.93637,5001,230,3756,615,348Jan 10, 2024, 10:31 AM
Bisker-Leib VeredChief Operating OfficerNov 17, 2023 Option Exercise$1.5064,41596,6231,420,499Nov 21, 2023, 02:10 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERNov 17, 2023 Option Exercise$1.5044,02566,0385,977,848Nov 21, 2023, 02:08 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERMar 10, 2023 Buy$3.3710,00033,7006,021,873Mar 10, 2023, 01:34 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERFeb 27, 2023 Buy$3.9820,00079,6006,011,873Feb 27, 2023, 11:39 AM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERFeb 15, 2023 Buy$3.8620,00077,2005,991,873Feb 15, 2023, 10:47 AM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERJan 31, 2023 Buy$4.0520,00081,0005,471,873Jan 31, 2023, 10:14 AM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERJan 24, 2023 Buy$4.1920,00083,8005,451,873Jan 24, 2023, 10:49 AM
Bisker-Leib VeredChief Operating OfficerNov 22, 2022 Sale$4.1914,92962,5531,069,985Nov 25, 2022, 04:41 PM
Bisker-Leib VeredChief Operating OfficerNov 25, 2022 Sale$4.36291,060,414Nov 25, 2022, 04:41 PM
Bisker-Leib VeredChief Operating OfficerNov 23, 2022 Sale$4.309,56941,1471,060,416Nov 25, 2022, 04:41 PM
Bisker-Leib VeredChief Operating OfficerNov 21, 2022 Sale$4.3416,03569,5921,084,914Nov 22, 2022, 04:15 PM
Bisker-Leib VeredChief Operating OfficerNov 18, 2022 Sale$4.406,22627,3941,107,175Nov 22, 2022, 04:15 PM
ORBIMED ADVISORS LLCDirectorNov 08, 2022 Buy$3.21402,0001,290,42015,219,994Nov 10, 2022, 04:44 PM
GORDON CARL LDirectorNov 08, 2022 Buy$3.21402,0001,290,42015,219,994Nov 10, 2022, 04:38 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERSep 28, 2022 Buy$2.3210,00023,2005,431,873Sep 28, 2022, 04:45 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERSep 26, 2022 Buy$2.2715,00034,0505,421,873Sep 27, 2022, 09:47 AM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERSep 07, 2022 Buy$3.0315,00045,4505,406,873Sep 08, 2022, 10:12 AM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERSep 01, 2022 Buy$2.8315,00042,4505,391,873Sep 01, 2022, 02:37 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERAug 10, 2022 Buy$2.6415,00039,6005,361,873Aug 10, 2022, 10:51 AM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERAug 01, 2022 Buy$2.5815,00038,7005,346,873Aug 02, 2022, 09:15 AM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERJun 21, 2022 Buy$2.8020,00056,0005,331,873Jun 21, 2022, 01:41 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERJun 16, 2022 Buy$2.3420,00046,8005,311,873Jun 17, 2022, 04:46 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERJun 13, 2022 Buy$2.2930,00068,7005,291,873Jun 13, 2022, 03:59 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERJun 06, 2022 Buy$2.8330,00084,9005,261,873Jun 07, 2022, 11:50 AM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERJun 01, 2022 Buy$3.0320,00060,6005,231,873Jun 01, 2022, 12:33 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERMay 26, 2022 Buy$3.0420,00060,8005,211,873May 26, 2022, 02:58 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERMay 23, 2022 Buy$2.7218,35549,9265,191,873May 24, 2022, 08:09 AM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERMay 17, 2022 Buy$2.4720,21549,9315,173,518May 17, 2022, 03:17 PM
GORDON CARL LDirectorMay 13, 2022 Buy$2.4930,72276,49814,817,994May 13, 2022, 05:48 PM
GORDON CARL LDirectorMay 12, 2022 Buy$2.3597,094228,17114,787,272May 13, 2022, 05:48 PM
GORDON CARL LDirectorMay 11, 2022 Buy$1.7964,700115,81314,690,178May 13, 2022, 05:48 PM
ORBIMED ADVISORS LLCDirectorMay 13, 2022 Buy$2.4930,72276,49814,817,994May 13, 2022, 05:45 PM
ORBIMED ADVISORS LLCDirectorMay 12, 2022 Buy$2.3597,094228,17114,787,272May 13, 2022, 05:45 PM
ORBIMED ADVISORS LLCDirectorMay 11, 2022 Buy$1.7964,700115,81314,690,178May 13, 2022, 05:45 PM
ORBIMED ADVISORS LLCDirectorMay 10, 2022 Buy$1.6024,44739,11514,625,478May 10, 2022, 06:21 PM
ORBIMED ADVISORS LLCDirectorMay 09, 2022 Buy$1.5690,712141,51114,601,031May 10, 2022, 06:21 PM
ORBIMED ADVISORS LLCDirectorMay 06, 2022 Buy$1.6310,20016,62614,510,319May 10, 2022, 06:21 PM
GORDON CARL LDirectorMay 10, 2022 Buy$1.6024,44739,11514,625,478May 10, 2022, 06:19 PM
GORDON CARL LDirectorMay 09, 2022 Buy$1.5690,712141,51114,601,031May 10, 2022, 06:19 PM
GORDON CARL LDirectorMay 06, 2022 Buy$1.6310,20016,62614,510,319May 10, 2022, 06:19 PM
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERMay 10, 2022 Buy$1.8027,83650,1055,153,303May 10, 2022, 02:15 PM
GORDON CARL LDirectorNov 04, 2021 Buy$3.505,357,14318,750,00114,500,119Nov 08, 2021, 09:12 PM
ORBIMED ADVISORS LLCDirectorNov 04, 2021 Buy$3.505,357,14318,750,00114,500,119Nov 08, 2021, 09:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Bisker-Leib VeredCHIEF EXECUTIVE OFFICER02/08/202471,337
Schuetz Thomas J.PRESIDENT02/08/202464,934
Bisker-Leib VeredChief Executive Officer01/09/20243,383,531
Schuetz Thomas J.President of R&D01/09/20241,230,375
Bisker-Leib VeredChief Operating Officer11/17/202396,623
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER11/17/202366,038
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER03/10/202333,700
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER02/27/202379,600
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER02/15/202377,200
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER01/31/202381,000
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER01/24/202383,800
Bisker-Leib VeredChief Operating Officer11/22/202262,553
Bisker-Leib VeredChief Operating Officer11/25/20229
Bisker-Leib VeredChief Operating Officer11/23/202241,147
Bisker-Leib VeredChief Operating Officer11/21/202269,592
Bisker-Leib VeredChief Operating Officer11/18/202227,394
ORBIMED ADVISORS LLCDirector11/08/20221,290,420
GORDON CARL LDirector11/08/20221,290,420
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER09/28/202223,200
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER09/26/202234,050
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER09/07/202245,450
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER09/01/202242,450
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER08/10/202239,600
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER08/01/202238,700
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER06/21/202256,000
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER06/16/202246,800
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER06/13/202268,700
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER06/06/202284,900
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER06/01/202260,600
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER05/26/202260,800
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER05/23/202249,926
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER05/17/202249,931
GORDON CARL LDirector05/13/202276,498
GORDON CARL LDirector05/12/2022228,171
GORDON CARL LDirector05/11/2022115,813
ORBIMED ADVISORS LLCDirector05/13/202276,498
ORBIMED ADVISORS LLCDirector05/12/2022228,171
ORBIMED ADVISORS LLCDirector05/11/2022115,813
ORBIMED ADVISORS LLCDirector05/10/202239,115
ORBIMED ADVISORS LLCDirector05/09/2022141,511
ORBIMED ADVISORS LLCDirector05/06/202216,626
GORDON CARL LDirector05/10/202239,115
GORDON CARL LDirector05/09/2022141,511
GORDON CARL LDirector05/06/202216,626
Schuetz Thomas J.CHIEF EXECUTIVE OFFICER05/10/202250,105
GORDON CARL LDirector11/04/202118,750,001
ORBIMED ADVISORS LLCDirector11/04/202118,750,001
Load More Insider Transactions
FUNDS WITH A POSITION IN COMPASS THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC18,791,4220.84%-15.97%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.9,880,0000.03%54.86%Other
BLACKROCK INC.6,222,3090.00025%4.16%Other
BLACKSTONE INC.6,189,5510.04%No changeOther
VIVO CAPITAL, LLC3,556,0230.45%No changeOther
GEODE CAPITAL MANAGEMENT, LLC1,992,0280.00033%5.27%Other
BAKER BROS. ADVISORS LP1,557,6300.03%No changeOther
RENAISSANCE TECHNOLOGIES LLC176,7990.00043%559.7%Other
CHANGE IN SHARES OUTSTANDING FOR COMPASS THERAPEUTICS INC
STOCK BUYBACKS FOR COMPASS THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.14%
1Q
12/31/2023
06/30/2023
0.68%
2Q
12/31/2023
03/31/2023
0.97%
3Q
12/31/2023
12/31/2022
8.20%
4Q
12/31/2023
09/30/2022
26.32%
5Q
12/31/2023
06/30/2022
26.40%
6Q
12/31/2023
03/31/2022
26.51%
7Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.14%
1Q
06/30/2023
0.68%
2Q
03/31/2023
0.97%
3Q
12/31/2022
8.20%
4Q
09/30/2022
26.32%
5Q
06/30/2022
26.40%
6Q
03/31/2022
26.51%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR COMPASS THERAPEUTICS INC
LOADING...